ARCHIVES

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

Kirsten Goldberg Leaves The Cancer Letter For ASCO

January 7, 2011